Cool I got the first Post
Critique this one.... there is more to the story, but didnt want to crash the SI server on one post <g>
Oh look the CFO and the CEO's husband also own the Investor relations company... my my
Message 7562027
His wife biz contacts "when she was at the helm of CVIA" he was "just a paid consultant"
Message 5700785
Message 5701151
Their Biz buddy proudly displaying "the funding" on his former web site, a 1997 Reg S this is nice.
selectcapital.com
1997 Corporate Vision, Inc. Public computer software company Private placement of debentures $1,250,000
Making CD Roms one day and spring loaded hypodermic needles the next, of course once you get a Reg S most anything is possible, so you just buy another shell.
1/29/99 the hometown paper goes writes a very nice story, and hey they have a comment section at the bottom of the article !!!
tulsaworld.com.
Maxxon president Gifford Mbie (left) and medical director Dr. T.R. Coughlin Jr. display the company's new safety syringe.
STEPHEN HOLMAN / Tulsa World
A small Tulsa company says it has found a painless way to save lives and health care costs.
Maxxon Inc., a public company formed by Tulsa-based LG Group, is close to bringing to the foreign market a disposable medical syringe that guards against needle-stick injuries. The device would use an automatically retractable needle.
"We're in production for only one size, which will be used as samples for foreign distributors," said Gifford Mabie, president of Maxxon. "In fact, on Feb. 1 we're supposed to meet with a delegation from Russia that has indicated they'd like to buy some of the syringes."
Mabie said that while awaiting federal approval to launch the product on the U.S. market, his company will begin marketing to foreign distributors.
The market for syringes is 15 billion annually worldwide, and about 80 percent of it is outside the United States.
"These other countries don't require FDA approval -- they just want the things to work and the price to be competitive with a standard syringe. We've got that," Mabie said.
According to Mabie, about 478 safety syringes have either been patented or are in development. Retractable Technologies of Texas is the only company he knows of that has received approval from the U.S. Food and Drug Administration and made it to the $3 billion syringe market.
The Retractable Technologies device "has a spring, works like a ball point pen and functions flawlessly, but it's so expensive that nobody will buy it," Mabie said. "It's about five to ten times more expensive than the standard syringe."
This is where the Maxxon Safety Syringe will step away from its competitors, he said.
"What caught our attention at the very start was that the retraction method made this price-competitive with standard syringes," he said of the Maxxon product. "If a standard syringe costs a nickel and our syringe costs a nickel but protects against needle stick injuries, even a dummy will say, 'Yeah, I'll take the thing.' "
The Centers for Disease Control estimates that about 300 American health care workers die each year from diseases acquired through accidental needle sticks.
It took Maxxon two years to develop a product that provides value at a competitive cost, Mabie said. That process, although tedious for a new company, will be time well invested should future federal legislation follow California and require all health care providers to use only safety syringes.
But Mabie said he believes that even before his product enters the U.S. market, it will be highly successful.
"It's exciting -- it really is," he said. "We've been contacted by a total of 85 distributors or distributor/manufacturers from all over the world who are interested in buying Maxxon or acquiring the technology."
About 10 companies are interested in buying Maxxon or acquiring its technology to manufacture the safety syringe in their own country and distribute from there, Mabie said.
"We're seriously considering some of these proposals, because if you have a distributor in another country -- particularly a manufacturing distributor -- it adds value to the company."
And a higher value would bring a higher price when Maxxon is sold to a manufacturer -- a goal of the Tulsa group from the beginning.
|
